ALLMedicine™ Bone Tumors Center

May 1st, 2021 - The authors aimed to demonstrate the feasibility and advantages of carbon fiber-reinforced PEEK (CFRP) composite implants in patients with both primary and secondary osseous spinal tumors. Twenty-eight spinal tumor patients who underwent fixation ...

Apr 24th, 2021 - Chondroblastoma (CB) is a rare, primary, benign bone tumor that commonly affects men aged 15-20 years. It is usually detected in the epiphysis of the long bones, such as the proximal femur, humerus, and tibia. The patella is an infrequent site. CB...

Apr 15th, 2021 - Giant cell tumors of the bone (GCTB) are rare bone tumors, especially in the cervical spine. Generally considered benign, local aggressiveness and metastatic growth have been described. Surgical concepts for GCTB are challenged by complex neurovas...

Apr 12th, 2021 - Osteoblastomas are rare, benign, bone-forming neoplasms that represent less than 1% of all bone tumors and occur mostly in people aged 10 to 30 years. In long bones, the metadiaphyseal region tends to be most commonly affected. However, to the bes...

Apr 6th, 2021 - With the development of medical technology, credible options for defect reconstructions after the resection of benign bone tumors of the lower extremities have become a high priority. As the current reconstructive methods commonly used in clinical...

May 6th, 2020 - Although primary bone tumors are relatively uncommon, appropriate imaging evaluation is essential when they are suspected or incidentally detected. In almost all cases, radiographs are the most appropriate initial imaging study for screening and c...

Sep 30th, 2018 - Primary bone tumours are rare, accounting for < 0. 2% of malignant neoplasms registered in the EUROCARE (European Cancer Registry based study on survival and care of cancer patients) database [1].

Jan 31st, 2017 - The NCCN Guidelines for Bone Cancer provide interdisciplinary recommendations for treating chordoma, chondrosarcoma, giant cell tumor of bone, Ewing sarcoma, and osteosarcoma. These NCCN Guidelines Insights summarize the NCCN Bone Cancer Panel's g.

May 1st, 2021 - The authors aimed to demonstrate the feasibility and advantages of carbon fiber-reinforced PEEK (CFRP) composite implants in patients with both primary and secondary osseous spinal tumors. Twenty-eight spinal tumor patients who underwent fixation ...

Apr 24th, 2021 - Chondroblastoma (CB) is a rare, primary, benign bone tumor that commonly affects men aged 15-20 years. It is usually detected in the epiphysis of the long bones, such as the proximal femur, humerus, and tibia. The patella is an infrequent site. CB...

Apr 15th, 2021 - Giant cell tumors of the bone (GCTB) are rare bone tumors, especially in the cervical spine. Generally considered benign, local aggressiveness and metastatic growth have been described. Surgical concepts for GCTB are challenged by complex neurovas...

Apr 12th, 2021 - Osteoblastomas are rare, benign, bone-forming neoplasms that represent less than 1% of all bone tumors and occur mostly in people aged 10 to 30 years. In long bones, the metadiaphyseal region tends to be most commonly affected. However, to the bes...

Apr 6th, 2021 - With the development of medical technology, credible options for defect reconstructions after the resection of benign bone tumors of the lower extremities have become a high priority. As the current reconstructive methods commonly used in clinical...

Mar 18th, 2021 - NEW YORK (Reuters Health) - Radiofrequency ablation (RFA) for the palliative treatment of patients whose cancer has spread to the bone provides rapid and sustained pain relief and improves quality of life, according to new research. Radiation trea...

May 19th, 2019 - Metastatic bone disease is a secondary cancer that occurs when cells from the primary tumor migrate to a bone location. Cell migration can occur by attachment to a basement membrane of the blood vessel wall (ie, neovascularization) or migration to...

May 19th, 2019 - Metastatic bone disease is a secondary cancer that occurs when cells from the primary tumor migrate to a bone location. Cell migration can occur by attachment to a basement membrane of the blood vessel wall (ie, neovascularization) or migration to...

Jul 8th, 2018 - Bone Metastases Radionuclide Therapy European Association of Nuclear Medicine Indications for radionuclide bone therapy with beta-emitting radionuclides include, but are not limited to (1) Painful metastatic bone lesions with osteoblastic response...

Dec 3rd, 2015 - Eosinophilic granuloma represents less than 1% of all bone tumors, and adult presentation is very rare. The differential diagnosis of lytic bone lesions is broad and includes metastatic carcinoma, lymphoma/myeloma, osteomyelitis, osteoblastoma, an.